Idexx Laboratories (IDXX) Change in Receivables (2009 - 2026)

Idexx Laboratories has reported Change in Receivables for 18 years, with the latest figure at $26.0 million in Q2 2026.

• On a quarterly basis, Change in Receivables fell 12.19% year-over-year to $26.0 million in Q2 2026; TTM through Jun 2026 was $76.7 million, a 279.81% increase from a year earlier, with the FY2025 full-year figure at $68.7 million, up 143.01% from the prior year.
• Change in Receivables was $26.0 million for Q2 2026 at Idexx Laboratories, down from $56.8 million in the prior quarter.
• The five-year high for Change in Receivables was $56.8 million in Q1 2026, with the low at -$27.8 million in Q4 2024.
• Average Change in Receivables over 5 years is $15.3 million, with a median of $16.6 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Change in Receivables jumped 505.16% in 2022, then plunged 3953.5% in 2024.
• Over 5 years, Change in Receivables stood at $6.3 million in 2022, then slumped by 110.83% to -$686000.0 in 2023, then slumped by 3953.5% to -$27.8 million in 2024, then soared by 50.14% to -$13.9 million in 2025, then jumped by 287.8% to $26.0 million in 2026.
• The last three Change in Receivables figures came in at $26.0 million (Q2 2026), $56.8 million (Q1 2026), and -$13.9 million (Q4 2025), per Business Quant data.